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Abstract
Background: Tuberculosis remains an endemic public health problem, but the ecology of the TB
strains prevalent, and their transmission, can vary by country and by region. We sought to
investigate the prevalence of Mycobacterium tuberculosis strains in different regions of Venezuela. A
previous study identified the most prevalent strains in Venezuela but did not show geographical
distribution nor identify clonal genotypes. To better understand local strain ecology, we used
spoligotyping to analyze 1298 M. tuberculosis strains isolated in Venezuela from 1997 to 2006,
predominantly from two large urban centers and two geographically distinct indigenous areas, and
then studied a subgroup with MIRU-VNTR 24 loci.
Results:  The distribution of spoligotype families is similar to that previously reported for
Venezuela and other South American countries: LAM 53%, T 10%, Haarlem 5%, S 1.9%, X 1.2%,
Beijing 0.4%, and EAI 0.2%. The six most common shared types (SIT's 17, 93, 605, 42, 53, 20)
accounted for 49% of the isolates and were the most common in almost all regions, but only a
minority were clustered by MIRU-VNTR 24. One exception was the third most frequent overall,
SIT 605, which is the most common spoligotype in the state of Carabobo but infrequent in other
regions. MIRU-VNTR homogeneity suggests it is a clonal group of strains and was named the
"Carabobo" genotype. Epidemiologic comparisons showed that patients with SIT 17 were younger
and more likely to have had specimens positive for Acid Fast Bacilli on microscopy, and patients
with SIT 53 were older and more commonly smear negative. Female TB patients tended to be
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younger than male patients. Patients from the high incidence, indigenous population in Delta
Amacuro state were younger and had a nearly equal male:female distribution.
Conclusion: Six SIT's cause nearly half of the cases of tuberculosis in Venezuela and dominate in
nearly all regions. Strains with SIT 17, the most common pattern overall may be more actively
transmitted and SIT 53 strains may be less virulent and associated with reactivation of past
infections in older patients. In contrast to other common spoligotypes, strains with SIT 605 form
a clonal group centered in the state of Carabobo.
Background
There has evolved a genre of publications describing
aspects of the molecular epidemiology of tuberculosis in
varied populations of diverse countries [1-4]. While many
of the earlier studies were coupled with epidemiologic
investigation to identify routes and risk factors for trans-
mission [5-8], most recent publications describe strain
variation and the dynamics in the local population struc-
ture of Mycobacterium tuberculosis. While this change
reflects an increasing interest in the phylogeny of M. tuber-
culosis  and its correlation with factors underlying the
dynamics in the tuberculosis epidemic, it is also related to
the techniques used. Where IS6110 RFLP typing distin-
guishes between strains [9], spoligotyping [10] and
sequence polymorphisms [11-13], are suitable for large
studies on phylogeny and identification of genotype fam-
ilies. The more recent technique of minisatellite analysis
[14], MIRU-VNTR 24 loci, is less technically demanding
than the IS6110 RFLP typing technique, can discriminate
at strain level, and is also promising for use in phyloge-
netic studies [15]. However, this technique is laborious in
its manual form, and fairly expensive when 24 loci are
analyzed with an automated sequencer [16]. As spoligo-
typing is a robust, cheap, and easy-to-perform technique
for large scale studies, this is a pragmatic choice, which
can be complemented by the selective use of MIRU-VNTR
analysis with 24, 15, 12 or fewer loci [17] to discriminate
genotypes within clusters of strains showing identical spo-
ligotypes.
In Venezuela, the average national incidence of tuberculo-
sis is moderate, approximately 34 per 100,000 http://
www.who.int/globalatlas/predefinedreports/tb/
PPDF_Files/ven.pdf. However, the incidence is two to
three times higher in some isolated Amerindian popula-
tions, likely the result of prolonged deficiencies in control
programs, although improvements over the past few years
have made strains available for this study. A recent publi-
cation described the spoligotype patterns of M. tuberculosis
strains in Venezuela based on analysis of 670 isolates col-
lected in a nationwide drug resistance survey [18]. While
this study identified the predominant spoligotypes in the
country, it did not include epidemiologic data, nor infor-
mation on where in Venezuela each strain was obtained.
Also, because it was based on data from spoligotyping
alone, it could not discriminate clonal clusters.
The Laboratorio de Tuberculosis of the Instituto de Bio-
medicina and the Laboratorio de Genética Molecular at
IVIC, both in Caracas, have been working in collaboration
with the National TB Control Program and regional labs
in the Amazonas, Carabobo and other states, to imple-
ment routine cultures to improve TB diagnosis and con-
trol. The M. tuberculosis isolates described herein were
collected from 1997 through 2006, and while this group
of strains could be described as a convenience sample, it
is likely to be representative of the country as a whole. It
includes large numbers of isolates from the two biggest
cities in the center of the country – Caracas and Valencia,
as well as from two rural, largely Amerindian populations
– Delta Amacuro and Amazonas, located at widely sepa-
rated geographical poles, and also a smaller number of
isolates from other regions (Figure 1 and Additional file
1). Data on strains from the Amazonas [19], Carabobo
[20], and Delta Amacuro [21] states that have been
described separately but are included here in a broader,
national analysis.
The strains were first analyzed by spoligotyping, whereaf-
ter a subgroup of strains with the most prevalent spoligo-
types were further analyzed with MIRU-VNTR 24 loci
typing. We show the geographic distribution of spoligo-
types, including a large, geographically centered clonal
outbreak, and associate the spoligotype results with epide-
miologic parameters to suggest that particular genotypes
of M. tuberculosis are emerging in Venezuela while others
may be disappearing.
Results
Clustering Analysis of Spoligotypes
A total of 300 different spoligotype patterns were recog-
nized among the 1298 strains subjected to analysis, of
which 201 were unique patterns, and 99 were shared with
other isolates, constituting clusters (Additional file 2).
Thirty-two clusters comprised only two cases. Of the 300
patterns, 173 were not found in SpolDB4 [10], and ofBMC Infectious Diseases 2009, 9:122 http://www.biomedcentral.com/1471-2334/9/122
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these 32 were shared and 141 were unique types. Of the
127 spoligotypes that have counterparts in SpolDB4, 9
patterns have been found exclusively in Venezuela: ST
1696, belonging to the family LAM5, 21 isolates; ST 1702,
LAM5, 10 isolates; ST 375, LAM5, 7 isolates; ST 1692, ×1,
5 isolates; ST 1698, U, 3 isolates; and one isolate each of
ST 1104, T5; 1700, T1; ST 1711 LAM2; and ST 1718, X1-
LAM9.
The most common spoligotype families were LAM (53%),
T (10.6%), and Haarlem (5%), but 17.9% could not be
classified (Figure 2). Using the program SPOTCLUST to
predict the most likely family, a similar distribution was
obtained for the 32 cluster spoligotypes (91 isolates) not
found in SpolDB4 (Additional file 2).
The six most common spoligotypes (Figure 3) were
Shared Types (SIT's) 17, 93, 605, 42, 53 and 20, which
together accounted for 49% of the total isolates. The sin-
gle most common pattern, SIT 17, was found in 242 iso-
lates (18.6%). The most common spoligotypes overall
were also the most common in each region, with SIT 17
being the first or second most frequently isolated in all
regions studied.
Although SIT 605 is relatively uncommon in most
regions, it was the third most common spoligotype over-
all because the collection includes 467 strains (36% of the
total) from the state of Carabobo, where it is the most
common pattern. It is present in SpolDB4, but the only
two strains with SIT605 described outside of Venezuela
Map of Venezuela showing the geographic origin of isolates included in the study Figure 1
Map of Venezuela showing the geographic origin of isolates included in the study.
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were isolated in New York in patients from Colombia (Jef-
frey Driscoll, Natalia Kurepina and Barry Kreiswirth, per-
sonal communication), which shares a long border with
Venezuela.
In SpolDB4, SIT 605 is not clearly assigned to a major gen-
otype family, but the absence of spacers 21 to 24 and 33
to 36 would place it in the LAM family, even though it also
lacks spacers 31 – 32 and 37 – 40. To confirm its designa-
tion as LAM, 45 chromosomal SNPs [13] were analyzed
for 23 strains, including 4 SIT 605, 4 SIT 17 and 4 SIT 93.
SIT 605 was found to belong to SCG v-ST7, as were the SIT
17, SIT 93 strains, as well as the other 11 strains with dif-
ferent LAM spoligotypes (data not shown). If SIT 605 is
classified as a LAM strain, this family would account for a
total of 60.2% of the isolates in this study.
MIRU-VNTR 24 Loci Analysis
To determine the genotype similarity of strains sharing
identical spoligotype patterns, we performed MIRU-VNTR
24 loci analysis on a subgroup of strains representing the
major spoligotype clusters (Figure 4). MIRU-VNTR con-
firmed the spoligotyping designation in all strains. Sur-
prisingly, while only occasional strains with SIT 17 or SIT
93 shared MIRU-VNTR 24 patterns, all SIT 605 strains
were identical for at least 21 loci, even if the strains had
been isolated at distinct geographic regions, suggesting
that SIT 605 comprises a clonal group of strains. Even the
two SIT 605 strains isolated in New York also appeared to
be part of this clone, based on previous MIRU 12 results
(Jeffrey Driscoll personal communication). We propose
naming this strain the "Carabobo" genotype. Further-
more, ST 1698, whose spoligotype pattern differs from SIT
605 by the absence of one additional spacer, was found by
MIRU-VNTR 24 to belong to the SIT 605 "Carabobo" gen-
otype.
Correlation with Epidemiologic Parameters
Epidemiologic data was not available for all of the
patients from whom the 1298 strains had been isolated,
but for several parameters the information was recorded
for at least 25% of the 1298 patients. Overall, of those
patients with available data, the mean age was 38 years,
68% were between 15 and 45 years of age, while 29%
were over 45, and just 3% were less than 15 years old.
Sixty nine percent were men, 74% had a positive clinical
specimens, 88% had pulmonary disease, and 75% had
cavitations according to the chest X-rays (data not
shown). Venezuelans made up 93% of patients and for-
eign-borns just 7%. The distribution of spoligotype pat-
terns in isolates from the foreign born population did not
appear different from that of native Venezuelan patients.
Comparisons of patients in different regions revealed that
the average patient age was similar for the two urban areas
– 39 years for Carabobo and 37.8 years for Caracas – and
36.8 years for the Amazon region (Table 1). However it
was much younger, 32.6 years, for patients from the indig-
enous Delta Amacuro region. Also, while males made up
about 71% of patients from Caracas, 70% from Carabobo
(69%) [20], and 64% from Amazonas [19], males com-
prised only 54% of the patients from Delta Amacuro [21].
Distribution of Spoligotype Families Figure 2
Distribution of Spoligotype Families. A. Distribution of Venezuelan M. tuberculosis biogeographic families defined by 
SpolDB4. B. Distribution of Venezuelan M. tuberculosis spoligotypes absent in SpolDB4 and identified at a family level by SPOT-
CLUST. NF= Not found in SpolDB4. FNDS= Family not described in SpolDB4.
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Surprisingly, female patients had significantly lower mean
ages overall, and also in Caracas and in Delta Amacuro
(Table 1).
There were no significant differences when all patients in
clusters were compared with all patients with non-clus-
tered isolates. However, Table 2 shows that patients
whose isolates had the most common spoligotype, SIT 17,
were significantly younger compared to patients with
other spoligotype strains (mean ages 34 vs 39 years, p =
0.0008). The SIT 17 patients also had lower mean ages
when the comparisons were stratified for each of the three
regions with the most isolates, but the differences did not
quite reach statistical significance (Caracas 35 vs 38.4, p =
0.077; Carabobo 34.5 vs 39.8 p = 0.076; and Amazonas
30.6 vs 39.1, p = 0.056). In contrast, patients with SIT 53
had a significantly higher mean age compared to all other
patients (48.2 vs 37.6, p = 0.001), or compared within the
Caracas cohort (50.25 vs 37.1, p = 0.0002), the source of
most SIT 53 patients with epidemiologic data. The mean
ages for patients in the other large clusters weren't signifi-
cantly different from the overall group (data not shown).
As seen in Table 3, patients with SIT 17 isolates were also
more likely to have had clinical specimens positive for
Acid Fast Bacilli (AFB) by microscopy when compared
Geographic Distribution of the Most Common Spoligotypes in Venezuela Figure 3
Geographic Distribution of the Most Common Spoligotypes in Venezuela. Spoligotypes found in at least 5 isolates, 
ranked by number of isolates, with SIT, Spoligotype family (SpoDB4), geographic distribution, and percentage of total strains 
(1298). Cs = Caracas, Cb= Carabobo State, Da = Delta Amacuro State, Am = Amazonas State; Suc = Sucre State, Ap = Apure 
State, and Ar = Aragua State. For spoligotypes not represented in SpolDB4, the "*" next to the family designation indicates the 
probability of belonging to that family as determined by the program SPOTCLUST.
            Cs  Cb Da Am Su Ap Ar 
          Total 572 467 84 100 54 12  9 
Rank SIT  Family  Spoligotype  Total  %  44  36 6,5 7,7 4,2 0,9 0,7 
1  17  LAM2  ■■□■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 2 42  18,6  115 6 5 2 3 2 7  7  3 2 
2  93  LAM5  ■■■■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■  129  9,9  50  52  7  7  9  3  1 
3  605  U  ■■■■■■■■■■■■□■■■■■■■□□□□■■■■■■□□□□□□□□□□■■■  93  7,2  17  70   1  4  1 
4  42  LAM9  ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■  85 6,5  42  31  4 2 5  1 
5  53  T1  ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■  53  4,1 2 9  12  9  1  1  1  
6  20  LAM1  ■■□■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■  35 2,7  19  7  5  3  1  
7  50  Haarlem3  ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■ 22  1,7  15  3  1 2 1    
8  1696  LAM5  ■■■□□□■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 2 1  1,6  3  18       
9  34  S  ■■■■■■■■□□■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 20  1,5  16  3  1     
10  51  T1  ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■□□□□  19  1,5  14  3  1     1 
11  376  LAM3  □■■■■■■■□□□■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■  16  1,2  8  6       2 
12  33  LAM3  ■■■■■■■■□□□■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■  13  1 6  7       
13  47  Haarlem1  ■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□■□□□□■■■■■■■  13  1  3  10       
14  4  LAM3- S 
conver  □□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■□□□□■■■■■■■  12 0,9  11  1       
15  64  LAM6  ■■■■■■■■■■■■■■■■■■■■□□□□■■■■□■■■□□□□■■■■■■■  10 0,8  5  1  1  3    
16  106  U ?  ■■■■■■■■□□□■■■■■■■■□□□□□□□□□□□□□□□□□□□■■■■■  10 0,8 2    8     
17  1702  LAM5  □□□□■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■  10 0,8  3  7       
18  NA  LAM2 
*0.82  ■■□■■■■■■■■■□■■■■■■■□□□□■■■■■□□■□□□□■■■■■□□  10 0,8  2    8    
19  62  Haarlem1  ■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□■□□□□■■■□■■■  9 0,7 2 2    5    
20  960  LAM5  ■□□■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■  9 0,7  9       
21  1691  LAM2  ■■□■■■■■■■■■□■□■■■■■□□□□■■■■■■■■□□□□■■■■■■■  9 0,7  4  5       
22  162  LAM9  ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■□■■■■  8 0,6  2  6    
23 194  LAM2-
LAM4 
■■□■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■□■■■ 8 0,6  2 2  4    
24 291  T1  ■■■■■■■■■■■■■■■■■■■■□■■■■■■■■■■■□□□□■■■■■■■ 7  0,5  7       
25 375  LAM5  □□□■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 7 0,5  5 2        
26 1694 LAM5  □■□■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 7 0,5  5  1  1    
27 866  LAM9  ■□■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 6 0,5  5 1        
28 1  Beijing  □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 5  0,4  5       
29 86  T1  ■■■■■■■■■■■■■■■■■■■■■□■■■■■■■■■■□□□□■■■■■■■ 5 0,4    5      
30 150  LAM9  ■■■■■■■■■■■■■■□■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 5 0,4  1 4        
31 167  T1  ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■■□□□□■■■■■■■ 5  0,4  3     2    
32 334  T1  ■□■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 5  0,4  5       
33 905  U  ■■□■■■■■■■■■□■■■■■■■□□□□■■■■■■□□□□□□■■■■■■■ 5 0,4  1  3  1   
34 1692 X1  ■□□□□■■■■□□■□■■■■□■■■■■■■■■■■■■■□□□□■■■□■■■ 5 0,4  2 3        
35 1905 T1  ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□■■□□□□■■■■■■■ 5 0,4      5    
36 NA  T1  *1,00  ■■■■■■■■■■■■■■■■■■■■□■■■■■■■■■■■□□□□■■□■■■■ 5 0,4      5    BMC Infectious Diseases 2009, 9:122 http://www.biomedcentral.com/1471-2334/9/122
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overall, or just within the Caracas cohort, but the differ-
ences were only significant compared to other Caracas
patients (SIT 17 vs non-SIT 17, all patients: OR = 1.47, p
= 0.14; Caracas: OR = 1.96, p = 0.04). Within the Caracas
group, specimens from patients with the SIT 53 spoligo-
type were less likely be AFB positive, but the difference
was not statistically significant (OR = 0.68, p = 0.55).
However, there were only 20 Caracas SIT 53 patients with
AFB microscopy results. The difference was more marked
when AFB positivity was compared between Caracas
Dendrogram of Venezuelan M. tuberculosis strains Figure 4
Dendrogram of Venezuelan M. tuberculosis strains. Dendrogram combining MIRU-VNTR and Spoligotype results from 
representative strains generated by Bionumerics software (Applied Maths) using the unweighted pair group method of aver-
ages (UPGMA). MIRU patterns with 3 or fewer changes are considered clonal. Inside the box are the SIT 605 strains defined as 
clonal by spoligo and by 24 MIRU- VNTR loci. Only MIRU 12 results were available for the strains of SIT 605 isolated in New 
York.
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patients with SIT 17 and SIT 53, but still failed to reach
statistical significance (OR = 2.44, p = 0.14).
Discussion
We have used Spoligotyping to analyze M. tuberculosis
strains isolated in different parts of Venezuela, and while
the collection could be described as a convenience sam-
ple, without proportionate geographic or temporal distri-
bution, it likely reflects the prevalence of strains in the
entire country, as the spoligotypes are generally the same
as those found in a previous study based on a propor-
tional nationwide sampling to determine prevalence of
drug resistance [18]. There are a total of approximately
6500 cases of tuberculosis reported per year in Venezuela,
so for the ten years during which strains were collected,
the sample represents only ~2% of registered cases, but
5% for Caracas and a larger percentage for Valencia and
the Carabobo state of which it is the capital.
As in other studies in South America [18,22,23] the LAM
family predominates, accounting for 53% of all strains,
and 60% if, as suggested by the SNP results, SIT 605 is also
considered LAM. Although 300 different spoligotype pat-
terns were found, only 6 accounted for almost 50% of the
isolates, and these patterns were the most common in
nearly all the regions sampled. In contrast, 201 patterns
were found in only one isolate, and 173 (57.7%) of these
were not present in SpolDB4. Nine of the 127 patterns
that are represented in SpolDB4 have been found exclu-
sively in Venezuela, and a tenth, SIT 605, has been iso-
lated outside of Venezuela only in New York, in two
immigrants from the neighboring country of Colombia.
This last spoligotype, SIT 605, is perhaps the most surpris-
ing finding in this study, because unlike the other com-
mon spoligotypes such as SIT 17 and 93, which contain a
number of distinct genotypes when analyzed by MIRU-
VNTR 24 loci, SIT 605 appears to represent a large clonal
cluster that is geographically centered around the city of
Valencia and the state of Carabobo [20], but encompasses
almost all the SIT 605 strains examined, including the two
isolated in New York. The previous study [18] of the
molecular epidemiology of M. tuberculosis strains in Vene-
zuela found several isolates with SIT 605, but as that study
was based on spoligotyping without geographic data, the
focal and clonal nature of this genotype could not have
been detected. We propose that the SIT 605 strains be
termed the "Carabobo" genotype.
Phylogeographic analysis of spoligotypes have identified
a number of regionally originating patterns or clades
whose isolates have similar patterns with RFLP IS6110
and appear to represent strains with a common lineage.
The most notorious example is SIT 1, or Beijing, which
presumably originated in Asia and has spread widely [24].
Other examples are the SIT 33/F11/LAM clade [25] first
described in South Africa, the SIT 60/F15/LAM4 KZN
clade associated with XDR-TB in Kwazulu Natal, South
Africa [26], the SIT 61/LAM10 Cameroon clade, SIT 59/
LAM11/ZWE/MERU, SIT 21/CAS1-Kili, SIT 26/CAS1-
Dehli, SIT 41/LAM7-Tur, and SIT 19/Manila/EAI2
[10,27]. These clades are not homogeneous, but include
several related MIRU-VNTR and RFLP IS6110  patterns,
Table 1: Comparison of mean ages of TB patients whose isolates were included in this study
Overall Amazonas Caracas Carabobo Delta Amacuro Sucre Apure
N° of individuals 1298 100 572 467 84 54 12
Individuals with age data 766 100 410 212 22 15 7
Mean age
(years)
38.0
(37–39)
36.8
(33–41)
37.8
(36–39)
40.0
(37–41)
31.2
(23–39)
44.7
(34–55)
42.6
(27–58)
N° of females 304 36 151 66 33 11 4
% Females 31 36 29 30 46 24 33
Female with
age data
241 36 118 66 13 6 2
Mean Female age
(years)
36.2
(34–38)
38.5
(32–45)
35.1
(32–38)
37.6
(33–42)
24.5
(15–34)
48.8
(30–67)
N° of males 670 64 373 157 38 34 8
% Males
Males with
age data
525 64 292 156 9 9 5
Mean Male Age 38.8
(37–40)
35.8
(31–41)
38.8
(37–41)
39.6
(37–42)
40.9
(28–54)
42.0
(30–54)
Difference M/F
Mean age
p value
0.05 0.52 0.03 0.39 0.05 0.54
The mean ages are shown for the entire group and also separated by region and gender. In each category, the age was available only for the number 
of patients indicated with age data. Confidence intervals are shown in parentheses. Determination of mean ages, confidence intervals and statistical 
significance using the Student's two -tailed T test assuming equal variance were performed within Excel. Statistically significant p values are shown in 
bold.BMC Infectious Diseases 2009, 9:122 http://www.biomedcentral.com/1471-2334/9/122
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some of which may comprise more localized clonal clus-
ters. However, the fact that these spoligotype families
have a wide distribution, and some are associated with
MDR outbreaks, suggests that they have selective advan-
tages over other strains in their ability to cause disease and
be transmitted. It appears that SIT 17, and perhaps SIT 93,
might similarly be considered successful clades, as they
are responsible for 18.6% and 9.9%, respectively, of
tuberculosis cases in Venezuela, and have been found in
several other countries.
There are also reports of spoligotype patterns that are geo-
graphically limited and appear to be clonal by MIRU/
RFLP analyses, such as the SIT 2643 Haarlem3 strain in
Paraguay [22], but the number of isolates of these clonal
genotypes is generally small. An examination of SpolDB4
[10] shows several SIT's with more than 10 isolates lim-
ited to one country, or with a single additional isolate in
a separate country, perhaps from an emigrant (for exam-
ple, SIT's 210, 339, 1258, 1329, 1457, 1518, and 1898).
Similarly, in Additional file 2 there are, besides SIT 605,
other spoligo patterns that could represent clonal strains
because they are found only in particular regions of Vene-
zuela, for example the putative LAM2 strain in position 18
(Figure 3). Several of these are currently being analyzed by
MIRU-24 loci. However, it is striking that the SIT 605/SIT
1698 Carabobo genotype is the most common spoligo-
type in a state with a population greater than 2 million,
accounting for 15% of all isolates, while it is relatively
uncommon in the other regions we sampled. However, of
only nine isolates obtained from the state of Aragua,
which borders Carabobo, one was SIT 605, so it is possi-
ble that this strain is also common in adjacent areas. As
the spoligotype for the Carabobo strain evolved with the
loss of spacers 31–32 and 37 – 40, other elements of the
genome could have, independently, evolved to gain an
unknown selective advantage over other local M. tubercu-
losis genotypes, but unlike SIT 17, there were no epidemi-
Table 2: Comparison of mean ages of TB patients with SIT 17 or SIT 53 spoligotype patterns
Overall Caracas Carabobo Amazonas Delta Amacuro Sucre Apure
N° of isolates 1298 572 467 100 84 54 12
% with age 59 72 45 100 25 28 58
Mean age 37.6 37.8 39.0 36.8 32.6 44.7 42.6
(36–39) (36–39) (37–41) (33–41) (24–41) (34–55) (27–58)
SIT 17 242 115 65 27
% with age 64 66 52 100
Mean age 34 35 34 31
(32–36) (32–38) (30–39) (24–37)
Non SIT 17 1056 457 402 73
% with age 58 73 44 100
Mean age 39 38 40 39
(38–40) (37–40) (37–42) (34–44)
17 vs non 17 P = 0.0008 P = 0.077 P = 0.076 P = 0.056
SIT 53 53 29
% with age 42 69
Mean age 48 50
(42–57) (42–58)
Non SIT 53 1245 544
% with age 60 72
Mean age 38 37
(36–39) (36–39)
53 vs non 53 P = 0.001 P = 0.0002
Non 53 non 17 1004 413
% with age 59 76
Mean age 38.63 37.7
(37–40) (36–39)
53 vs non 53 non 17 P = 0.003 P = 0.0005
The table shows the mean age of all patients with age data in the study as a single cohort and also divided by region. Statistical comparisons are 
shown between patients with SIT 17 and patients with other spoligotypes and, separately, between SIT 53 and other spoligotypes. Confidence 
intervals are shown in parentheses. Mean values, confidence intervals, and P values with the Student's two-tailed T test assuming equal variance 
were performed within Excel. Statistically significant p values are shown in bold.BMC Infectious Diseases 2009, 9:122 http://www.biomedcentral.com/1471-2334/9/122
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ologic correlations suggesting higher virulence. At least six
SIT 605 patients were present or former inmates in a par-
ticular prison in Carabobo state, and it appears that other
SIT 605 patients had contact with people that were
interned in that prison, so this institution could play a
role in its local dissemination, as described for other
prison-associated clonal outbreaks [28,22,29].
Although at least one SIT 605 isolate was found to be
Multi-Drug Resistant [18], the great majority of SIT 605
isolates were pan-sensitive. Our study found only a very
few Beijing isolates, some of them lethal MDR strains
(National Tuberculosis Program, unpublished data), but
fortunately they do not appear to have been transmitted
extensively within the Venezuelan population [30]. At
least one of the Beijing strains was isolated from a Peru-
vian national [31].
The comparisons of epidemiologic and clinical parame-
ters revealed that in the indigenous Warao population in
Delta Amacuro [21] tuberculosis occurs at younger ages
(mean of 32.6 years) than in the rest of the population
(mean of 38–39 years), and unlike the 71% male predom-
inance in the cities, there is a nearly equal male:female
distribution (54%). This pattern is consistent with very
active spread within this isolated Amerindian community
[21] that has the highest TB incidence in Venezuela and
amongst the lowest life expectancies. The data from the
largely Amerindian tuberculosis population in the Ama-
zonas states [19] suggests a similar, but less marked trend,
with an average age of 36.8 that is 64% male. More
polemical are the findings suggesting that SIT 17 may be
more actively transmitted because patients with isolates
belonging to the SIT 17 cluster tended to be younger and
were more likely to have AFB positive specimens. Low
patient age is considered characteristic of strains being
actively transmitted [32]. In contrast, SIT 53 may be less
virulent because patients with this spoligotype tended to
be older and may have more AFB negative sputa, but the
AFB trend did not reach statistical significance, and the
older age, while reaching statistical significance, was
based on only 21 SIT 53 patients and needs to be con-
firmed in subsequent studies.
These associations provoke a number of questions. If SIT
53 were really less virulent, why is it still the sixth most
common spoligotype, causing 4% (53) of cases? Could it
have been a very common strain in the past, that is now
more apt at latency and reactivation than person-to-per-
son transmission, and will its prevalence decrease over
time? SIT 93 is the second most common spoligotype,
found in 10% of all isolates, but why isn't it also associ-
ated with clinical parameters suggesting virulence and
transmission? Finally, preliminary MIRU-VNTR analysis
suggests that all of the most common spoligotype clusters,
except for SIT 605, contain several different strain geno-
types. Therefore, for the epidemiologic associations with
SIT 17 or SIT 53 to make sense, it must be assumed that
the strains with these spoligotypes derived from a com-
mon ancestor with genetic characteristics that were main-
tained even as the MIRU-VNTR patterns evolved, as seems
true for globally dispersed lineages such as Beijing.
Finally, it must be recalled that clinical data was not avail-
able for many of the patients whose isolates comprised
this study, so although all data were collected before spo-
ligotyping results were known, the epidemiologic associa-
tions with SIT 17 could be subject to biases due to regional
differences in patient admission or data recording. We
attempted to reduce this possibility through regional strat-
ification, and found that associations for SIT 17 persisted,
Table 3: Comparison of specimens whose cultures grew isolates with SIT 17 or SIT 53 for percentage that were positive for Acid Fast 
Bacilli by microscopy
All All w/o
SIT 17
All SIT 17 CCS all CCS w/o SIT 17 CCS SIT 17 CCS w/o SIT 53 CCS SIT
53
Total 1298 1054 244 572 457 115 543 29
% with
data
48 48 50 53 53 51 52 69
Positive 463 366 97 178 136 42 168 10
Negative 164 139 25 125 108 17 115 10
% positive 74 72 80 59 56 71 59 50
All: CCS: CCS: CCS:
Comparison 17 vs non 17 17 vs non 17 53 vs non 53 17 vs 53
Odds ratio OR= 1.47 OR= 1.96 OR= 1.46 OR= 2.44
(0.91–2.43) (1.06–3.7) (0.57–3.7) (0.84–7.11)
P = 0.14 P = 0.04 P = 0.55 P = 0.14
Comparisons were made based on the patients with microscopy data. The percentage of specimens that were AFB positive was compared between 
those that grew strains with either spoligotype SIT 17 or SIT 53, and those from which strains with all other patterns were isolated. Comparisons 
were made for all specimens in the study, and separately, for those obtained in Caracas (CCS). Two by two table comparisons with odds ratios and 
Yates corrected two-tail chi square values were calculated using OpenEpi http://www.openepi.com. Statistically significant p values are shown in 
boldBMC Infectious Diseases 2009, 9:122 http://www.biomedcentral.com/1471-2334/9/122
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although not always reaching statistical significance. If
subsequent studies with more complete data confirm that
the SIT 17 or SIT 53 spoligotypes, or the SIT 605 Carabobo
genotype, are associated with particular clinical disease
characteristics, the challenge will be to identify the molec-
ular basis for these apparent differences.
Conclusion
Six spoligotypes accounted for 49% of the 1298 M. tuber-
culosis Venezuelan isolates analyzed, and the most com-
mon overall were the most common in all regions
examined. The patients with isolates showing spoligotype
SIT 17 tended to be younger and more likely to have had
AFB positive specimens, suggesting that these strains are
being actively transmitted. In contrast, SIT 53 may be
more common in cases of reactivation, as the patients
with these strains tended to be older and may be less likely
to be AFB positive. MIRU-VNTR 24 showed that only a
minority of strains in the most common spoligotypes
were clustered, with the exception of SIT 605 strains,
which appear to be clonal. SIT 605 was named the "Cara-
bobo" genotype because it is the most common spoligo-
type in this state, but infrequently seen in other regions of
Venezuela. The only two strains with SIT 605 described
outside of Venezuela were isolated in New York in
patients from Colombia, and also belong to the SIT 605
cluster. Overall, female patients had lower mean ages than
male patients. Tuberculosis patients in the Amerindian
Warao population in the state of Delta Amacuro had a
lower mean age and a more equal male:female distribu-
tion, possibly reflecting the active transmission that gives
this population the highest incidence of tuberculosis in
the country.
Methods
M. tuberculosis strains
The 1298 clinical isolates in this report were obtained
from an equal number of different patients between 1997
and 2006 (Additional file 1) as part of an ongoing study
of M. tuberculosis strains from different geographic regions
of Venezuela (Figure 1). They are largely from two large
urban regions, Caracas (pop. > 5 million), the national
capital (n = 572), and Valencia (pop. >1.5 million), capi-
tal of the state of Carabobo (Pop. > 2.2 million) (n = 467),
and two relatively isolated states with large and distinct
Amerindian populations, Delta Amacuro – where the
Warao inhabit the wide delta of the Orinoco River (n =
84) and Amazonas (n = 100), home to many Amerindian
ethnicities. Smaller numbers of strains were also obtained
from the states of Apure (n =12), Aragua (n = 9) and Sucre
(n = 54). The isolates were obtained by culturing sputa or
non-pulmonary clinical specimens using either the Petroff
method with Löwenstein – Jensen slants or the Kudoh
method with Ogawa slants [33] The criteria for culturing
clinical specimens varied by region. All that were positive
for Acid Fast Bacilli by microscopy were cultured, but
some regions, such as Carabobo, also cultured specimens
from patients that were symptomatic and had abnormal
chest X-rays or were otherwise highly suspicious for hav-
ing TB. In Caracas all specimens from patients with respi-
ratory symptoms for more than two weeks were cultured.
Spoligotyping
Spoligotyping was performed as previously described by
Kamerbeek [34]. The spacer sequences contained in the
direct repeat locus were detected by hybridization onto
either homemade or commercially prepared spoligotyp-
ing membranes. DNAs from M. tuberculosis H37Rv and M.
bovis BCG were used as positive controls, and spoligotyp-
ing was repeated until results were unambiguous. Each
spoligotype was converted to octal format [35] and com-
pared with the International Spoligo Database, SpolDB4
[10]. SPOTCLUST, an on-line program developed by Vitol
et al. [36], was used to tentatively assign phylogeographic
families to spoligotype patterns not present in SpolDB4.
Patient data, including age, sex, nationality, HIV status,
AFB positivity of the original clinical specimen, treatment
history, and chest X-ray information were included, when
available, in the spreadsheets that contained the spoligo-
typing results.
MIRU-VNTR Genotyping
Twenty four loci were amplified using multiplex PCR and
run with Rox labeled Map Marker 1000 size standards
(Bioventures) on ABI 3130 xl sequencers as described
[14,16,37,38]. Sizing of the PCR fragments and assign-
ments of MIRU-VNTR alleles were done with the Gene
Mapper software package (PE Applied Biosystems).
Cluster analysis
Spoligotyping and MIRU-VNTR profiles were also
recorded as character data and analyzed using Bionumer-
ics software (Applied Maths) or MIRU-VNTR plus, an on
line program developed by Allix-Béguec et al [39]. Den-
drograms were generated by using the categorical charac-
ter option and the unweighted pair group method of
averages (UPGMA) clustering method.
SNP Analysis
A subset of strains was analyzed for a set of 45 informative
SNPs as described [13].
Statistical analysis of epidemiologic data
The clinical and epidemiologic characteristics of patients
belonging to each of the six most common spoligotype
clusters were compared between these clusters and also
against all patients not in the analyzed cluster. Compari-
sons of sputum positivity were done as two by two tables
using the Yates corrected two-tail chi-square test on theBMC Infectious Diseases 2009, 9:122 http://www.biomedcentral.com/1471-2334/9/122
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OpenEpi website http://www.openepi.com. Mean age cal-
culations, confidence intervals and age comparisons with
the two-tailed T Test, assuming equal variance, were per-
formed within Excel. A p value of < 0.05 was considered
statistically significant.
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